-Jonathan D Chesnut Researcher Activity Profile

Research Author Detailed Information 

Jonathan D Chesnut Publication Rate By Year

Jonathan D Chesnut has published 6 paper(s) in 2007, 5 paper(s) in 2008, for a total of 11 research publications in total.

Jonathan D Jd Chesnut Author Information

LAST NAME: chesnut

FIRST NAME: Jonathan D

INITIALS: jd

AFFILIATION:

Papers

Jonathan D Chesnut's Publication Record

1. Qualification of embryonal carcinoma 2102Ep as a reference for human embryonic stem cell research. Year Published: 2007
GlobalStem, Inc., 6 Taft Court, Rockville, Maryland 20850, USA. rjosephson@globalstem.com
2. Self-renewal of human embryonic stem cells requires insulin-like growth factor-1 receptor and ERBB2 receptor signaling. Year Published: 2007
3. Self-renewal of human embryonic stem cells requires insulin-like growth factor-1 receptor and ERBB2 receptor signaling. Year Published: 2007
Division of Hematology, Department of Medicine, Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, 98195, USA.
4. Self-renewal of human embryonic stem cells requires insulin-like growth factor-1 receptor and ERBB2 receptor signaling. Year Published: 2007
Division of Hematology, Department of Medicine, Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, 98195, USA.
5. MicroRNA Expression Pattern of Undifferentiated and Differentiated Human Embryonic Stem Cells. Year Published: 2007
Invitrogen Corporation, Carlsbad, CA 92008.
6. Creation of engineered human embryonic stem cell lines using phiC31 integrase. Year Published: 2008
Invitrogen Corporation, Carlsbad, California 92008, USA. bhaskar.thyagarajan@invitrogen.com
7. MicroRNA expression pattern of undifferentiated and differentiated human embryonic stem cells. Year Published: 2007
Invitrogen Corporation, Carlsbad, CA 92008, USA. uma.lakshmipathy@invitrogen.com
8. Selection of transfected Mammalian cells. Year Published: 2008
Brigham and Women's Hospital, Boston, Massachusetts.
9. Selection of transfected mammalian cells. Year Published: 2008
Brigham and Women's Hospital, Boston, Massachusetts, USA.
10. Creation of engineered human embryonic stem cell lines using phiC31 integrase. Year Published: 2008
Invitrogen Corporation, Carlsbad, California 92008, USA. bhaskar.thyagarajan@invitrogen.com
11. Isolation of neural stem and precursor cells from rodent tissue. Year Published: 2008
Department of Human Genetics, University of Utah, Salt Lake City, UT, USA.